Clinical Trial Update: A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating the effect of SEP-363856 and prior antipsychotic standard of care on glucose and insulin regulation in schizophrenia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEP-363856

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED